Loria-Kanza Y

References (2)

Title : [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study] - Rigaud_2003_Presse.Med_32_1649
Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ , Loria-Kanza Y
Ref : Presse Med , 32 :1649 , 2003
Abstract :
PubMedSearch : Rigaud_2003_Presse.Med_32_1649
PubMedID: 14631268

Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil - Auriacombe_2002_Curr.Med.Res.Opin_18_129
Author(s) : Auriacombe S , Pere JJ , Loria-Kanza Y , Vellas B
Ref : Curr Med Res Opin , 18 :129 , 2002
Abstract :
PubMedSearch : Auriacombe_2002_Curr.Med.Res.Opin_18_129
PubMedID: 12094822